Yuzheng Zhao Selected Research

propanoldiaminetetracetic acid

4/2022	Light-switchable diphtherin transgene system combined with losartan for triple negtative breast cancer therapy based on nano drug delivery system.
1/2020	Safe and Efficacious Diphtheria Toxin-Based Treatment for Melanoma: Combination of a Light-On Gene-Expression System and Nanotechnology.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuzheng Zhao Research Topics

Disease

9	Neoplasms (Cancer) 04/2022 - 04/2015
3	Pathologic Processes 01/2020 - 01/2018
2	Breast Neoplasms (Breast Cancer) 04/2022 - 09/2020
2	Inflammation (Inflammations) 11/2021 - 09/2021
2	Colitis 11/2021 - 09/2021
2	Melanoma (Melanoma, Malignant) 10/2020 - 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Carcinogenesis 10/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 09/2021
1	Cholangiocarcinoma 05/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Leukemia 01/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021
1	Disease Progression 12/2020
1	Starvation 01/2020
1	Necrosis 01/2020
1	Cardiomegaly (Heart Hypertrophy) 01/2019
1	Cardiac Arrhythmias (Arrythmia) 01/2019
1	Adenocarcinoma of Lung 01/2019
1	Cardiomyopathies (Cardiomyopathy) 01/2019
1	Heart Failure 01/2019
1	Hypoxia (Hypoxemia) 01/2018
1	Wounds and Injuries (Trauma) 07/2017

Drug/Important Bio-Agent (IBA)

6	NAD (NADH)IBA 01/2022 - 04/2015
3	Pharmaceutical PreparationsIBA 09/2021 - 01/2019
3	Diphtheria ToxinIBA 10/2020 - 01/2020
2	Nanoparticle Drug Delivery SystemIBA 04/2022 - 09/2020
2	propanoldiaminetetracetic acidIBA 04/2022 - 01/2020
2	Dextrans (Dextran)FDA Link 11/2021 - 09/2021
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 11/2021 - 09/2021
2	Adenosine Triphosphate (ATP)IBA 01/2021 - 01/2019
2	Hyaluronic Acid (Hyaluronan)IBA 10/2020 - 09/2020
2	alpha-Tocopherol FDA Link 10/2020 - 09/2020
2	PolyethyleneimineIBA 10/2020 - 09/2020
2	Proteins (Proteins, Gene)FDA Link 10/2020 - 01/2018
2	Amino Acids FDA Link 01/2020 - 01/2018
2	NADP (NADPH)IBA 01/2018 - 07/2017
1	Transforming Growth Factors (Transforming Growth Factor)IBA 04/2022
1	Losartan (Cozaar)FDA LinkGeneric 04/2022
1	Collagen Type I (Type I Collagen)IBA 04/2022
1	CollagenIBA 04/2022
1	Fluorescent Dyes (Fluorescent Probes)IBA 11/2021
1	Phosphoglycerate Dehydrogenase (Dehydrogenase, Phosphoglycerate)IBA 10/2021
1	Serine (L-Serine)FDA Link 10/2021
1	EnzymesIBA 10/2021
1	Tacrolimus (Prograf)FDA LinkGeneric 09/2021
1	Methotrexate (Mexate)FDA LinkGeneric 05/2021
1	Gemcitabine FDA Link 05/2021
1	Folic Acid AntagonistsIBA 05/2021
1	osthol (osthole)IBA 01/2021
1	Carbonic Anhydrases (Carbonic Anhydrase)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Oxidoreductases (Dehydrogenase)IBA 01/2021
1	quinone (benzoquinone)IBA 01/2021
1	CarbonIBA 12/2020
1	AcidsIBA 10/2020
1	arginyl-glycyl-aspartic acidIBA 09/2020
1	DisulfidesIBA 09/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020
1	Ouabain (G Strophanthin)IBA 01/2019
1	Adenosine Monophosphate (AMP)IBA 01/2019
1	PPAR gammaIBA 01/2019
1	pyridineIBA 01/2018
1	isonitrosoacetophenoneIBA 07/2017
1	KP372-1IBA 05/2015
1	malic acid (malate)IBA 04/2015
1	Aspartic Acid (Aspartate)FDA Link 04/2015
1	Sirtuin 3IBA 04/2015

Therapy/Procedure

6	Therapeutics 04/2022 - 01/2019
1	Drug Therapy (Chemotherapy) 01/2021